Piot P. Uniting the world against AIDS // Speech at the Conference «Responsibility and Partnership — Together against HIV/AIDS». Bremen, 2007.

Беляков Н.А., Степанова Е.В., Рахманова А.Г. Характер и особенности ВИЧ-инфекции в Санкт-Петербурге // Медицинский академический журнал. 2009. Т. 9, № 3. C. 96–104. doi: 10.17816/MAJ9396-104..
DOI: 10.17816/MAJ9396-104

Pettit A.C. Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation // Journal of the International AIDS Society. 2018. Vol. 21, No. 1. e25031. doi: 10.1002/jia2.25031..
DOI: 10.1002/jia2.25031

Daas C.D., van den Berk G.E.L., Kleene M.-T. Health-related quality of life among adult HIV positive patients: assessing comprehensive themes and interrelated associations // Qual Life Res. 2019. doi: 10.1007/s11136-019-02203-y..
DOI: 10.1007/s11136-019-02203-y

Ming Z., Prybylski D., Cheng F., Airawanwat R., Zhu Q., Liu W. Two-year prospective cohort study on quality of life outcomes among people living with HIV after initiation of antiretroviral therapy in Guangxi, China // J. Association of Nurses in AIDS Care: JANAC. 2014. Vol. 25. Р. 603–613.

Dutra B.S., Lédo A.P., Lins-Kusterer L. Changes health-related quality of life in HIV-infected patients following initiation of antiretroviral therapy: a longitudinal study // The Brazilian J. Infect. Dis. 2019. Vol. 23, No. 4. P. 211–217. https://doi.org/10.1016/j.bjid.2019.06.005..
DOI: 10.1016/j.bjid.2019.06.005

Siddiqi A.E., Hall H.I., Hu X., Song R. Population‐based estimates of life expectancy after HIV diagnosis. United States 2008‐2011 // J. Acquir. Immune Defic. Syndr. 2016. Vol. 72. Р. 230–236.

Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high‐income countries: a collaborative analysis of 14 cohort studies // Lancet. 2008. Vol. 372, No. 9635. Р. 293–299.

Johnson L.F., Mossong J., Dorrington R.E., Schomaker M., Hoffmann C.J., Keiser O. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies // PLoS Med. 2013. Vol. 10, No. 4. e1001418.

Van Sighem A.I., Gras L.A., Reiss P., Brinkman K., de Wolf F; ATHENA national observational cohort study. Life expectancy of recently diagnosed asymptomatic HIV‐infected patients approaches that of uninfected individuals // AIDS. 2010. Vol. 24, No. 10. Р. 1527–1535.

Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV‐1‐infected patients treated with antiretroviral therapy, 1996‐2006: collaborative analysis of 13 HIV cohort studies // Clin. Infect. Dis. 2010. Vol. 50, No. 10. Р. 1387–1396.

Lima V.D., Lourenco L., Yip B., Hogg R.S., Phillips P., Montaner J.S. AIDS incidence and AIDS‐related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study // Lancet HIV. 2015. Vol. 2, No. 3. e92–97.

Granich R., Gupta S., Hersh B., Williams B., Montaner J., Young B. Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality Burden; 1990‐2013 // PLoS One. 2015. Vol. 10, No. 7. e0131353.

Buchacz K., Lau B., Jing Y. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000–2010 // J. Infect. Dis. 2016. Vol. 214, No. 6. Р. 862–872.

Masur, Henry. Recurring and emerging questions related to management of HIV-related opportunistic infections // Topics in Antiviral Medicine. 2018. Vol. 26, No. 3. Р. 79–84.

Беляков Н.А., Рассохин В.В., Розенталь В.В., Огурцова С.В., Степанова Е.В., Мельникова Т.Н., Курганова Т.Ю., Азовцева О.В., Симакина О.Е., Тотолян А.А. Эпидемиология ВИЧ-инфекции. Место мониторинга, научных и дозорных наблюдений, моделирования и прогнозирования обстановки // ВИЧ-инфекция и иммуносупрессии. 2019. № 11 (2). Р. 7–26.

Азовцева О.В., Трофимова Т.C., Архипов Г.С., Огурцова С.В., Пантелеев А.М., Беляков Н.А. Летальные исходы у больных с ВИЧ-инфекцией, параллели с адекватностью диагностики, диспансеризации и лечения // ВИЧ-инфекция и иммуносупрессии. 2018. № 10 (3). С. 90–101. https://doi.org/10.22328/2077-9828-2018-10-3-90-101..
DOI: 10.22328/2077-9828-2018-10-3-90-101

Яковлев А.А., Мусатов В.Б., Кузнецова А.В., Мейлахс А.Ю., Амирханян Ю.А., Чайка Н.А. Мнения специалистов о факторах, способствующих и препятствующих вовлечению и удержанию ВИЧ-инфицированных пациентов в системе медицинского сервиса // ВИЧ-инфекция и иммуносупрессии. 2015. Т. 7, No. 1. С. 101–107. https://doi.org/10.22328/2077-9828-2015-7-1-101-107..
DOI: 10.22328/2077-9828-2015-7-1-101-107

Незнанов Н.Г., Халезова Н.Б., Кольцова О.В., Селютина Е.В., Погодина С.А., Линец Ю.П., Емельянов О.В., Липская Е.В., Беляков Н.А. Психологические установки и толерантность медицинского персонала в работе с ВИЧ-инфицированными людьми // ВИЧ-инфекция и иммуносупрессии. 2015. № 7 (4). С. 28–40. https://doi.org/10.22328/2077-9828-2015-7-4-28-40..
DOI: 10.22328/2077-9828-2015-7-4-28-40

Беляков Н.А., Рассохин В.В., Бобрешова А.С. Противодействие ВИЧ-инфекции и рост заболеваемости в России // ВИЧ-инфекция и иммуносупрессии. 2017. № 9 (2). С. 82–90. https://doi.org/10.22328/2077-9828-2017-9-2-82-90..
DOI: 10.22328/2077-9828-2017-9-2-82-90

Пантелеев А.М., Драчева М.С., Никулина О.В., Соколова О.С., Зонова А.В. Клинико-лабораторные особенности микобактериоза у больных ВИЧ-инфекцией // Журнал инфектологии. 2016. Т. 8, № 3. С. 40–45.

Greene J.B., Sidhu G.S., Lewin S. et al. Mycobacterium avium-intracellulare: A cause of disseminated life-threatening infection in homosexuals and drug abusers // Ann. Intern. Med. 1982. Vol. 97. Р. 539.

Zakowski P., Fligiel S., Berlin O.G.W., Johnson B.L.Jr. Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency // JAMA. 1982. Vol. 248. Р. 2980–2982.

Jacobson M.A., Hopewell P.C., Yajko D.M. Natural history of disseminated Mycobacterium avium complex infection in AIDS // J. Infect. Dis. 1991. Nov., Vol. 164, No 5. Р. 994–998.

Corti М., Palmero D. Mycobacterium avium complex infection in HIV/AIDS patients // Expert Review of Anti-infective Therapy. 2008. Vol. 6, No. 3. Р. 351–363. doi: 10.1586/14787210.6.3.351..
DOI: 10.1586/14787210.6.3.351

Hawkins C.C., M.D., Estella J., M.D. et al. Mycobacterium avium Complex infections in patients with Acquired Immunodeficiency Syndrome // Ann. Intern. Med. 1986. Vol. 105. Р. 184–188.

Sathe S., Gascone P., Lo W., Pinto R., Reichman L.B… Severe Anemia Is an Important Negative Predictor for Survival with Disseminated Mycobacterium avium-intracellulare in Acquired Immunodeficiency Syndrome // AJRCCM. 1990. Vol. 142, No. 6, pt. 1.

Horsburgh C.R. Mycobacterium avium Complex Infection in the Acquired Immunodeficiency Syndrome // N. Engl. J. Med. 1991. Vol. 324, No. 19. Р. 1332–1338. doi: 10.1056/NEJM199105093241906..
DOI: 10.1056/NEJM199105093241906

Chiu J., Nussbaum J., Bozzette S. et al. Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group // Ann. Intern. Med. 1990. Vol. 113. Р. 358–361.

Horsburgh C.R., Gettings J., Alexander L.N., Lennox J.L. Disseminated Mycobacterium avium Complex Disease among Patients Infected with Human Immunodeficiency Virus, 1985–2000 // Clin. Infect. Dis. 2001. Vol. 33, Issue 11, 1 December. P. 1938–1943. https://doi.org/10.1086/324508..
DOI: 10.1086/324508

Hoy J., Mijch А., Sandland М., Grayson L., Lucas R., Dwyer B. Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients // The Journal of Infectious Diseases. 1990. Vol. 161, Issue 4, April. P. 801–805. https://doi.org/10.1093/infdis/161.4.801..
DOI: 10.1093/infdis/161.4.801

Sullam P.M., Gordin F.M., Wynne B.A. Rifabutin Treatment Group, Efficacy of Rifabutin in the Treatment of Disseminated Infection Due to Mycobacterium avium Complex // Clin. Infect. Dis. Vol. 19, Issue 1, July 1994, Р. 84–86. https://doi.org/10.1093/clinids/19.1.84..
DOI: 10.1093/clinids/19.1.84

Dautzenberg B., Truffot C., Legris S. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial // Am. Rev. Respir. Dis. 1991. Vol. 144. Р. 564–569.

Chaisson R.E., Benson C.A., Dube M.P. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team // Ann. Intern. Med. 1994. Vol. 121. Р. 905–911.

Chin D.P., Reingold A.L., Stone E.N. The Impact Of Mycobacterium Avium Complex Bacteremia And Its Treatment On Survival Of Aids Patients-A Prospective Study // J. Infect. Dis. 1994. Vol. 170, Issue 3, September. P. 578–584. https://doi.org/10.1093/infdis/170.3.578..
DOI: 10.1093/infdis/170.3.578

Cohn D.L., Fisher E.J., Peng G.T. Community Programs for Clinical Research on AIDS, A Prospective Randomized Trial of Four Three-Drug Regimens in the Treatment of Disseminated Mycobacterium avium Complex Disease in AIDS Patients: Excess Mortality Associated with HighDose Clarithromycin // Clin. Infect. Dis. 1999. Vol. 29, Issue 1, 1 July. P. 125–133. https://doi.org/10.1086/520141..
DOI: 10.1086/520141

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Downloaded from https://aidsinfo.nih.gov/guidelines on 6/24/2019.https://aidsinfo.nih.gov/guidelines

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Downloaded from https://aidsinfo.nih.gov/guidelines on 6/24/2019.https://aidsinfo.nih.gov/guidelines

Heifets L., Mor N., Vanderkolk J. Mycobacterium avium strains resistant to clarithromycin and azithromycin // Antimicrob Agents Chemother. 1993. Vol. 37. Р. 2364–2370.

Shafran S.D., Singer J., Zarowny D.P. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group // N. Engl. J. Med. 1996. Vol. 335. Р. 377–383.

Benson C.A., Williams P.L., Currier J.S. AIDS Clinical Trials Group 223 Protocol Team, A Prospective, Randomized Trial Examining the Efficacy and Safety of Clarithromycin in Combination with Ethambutol, Rifabutin, or Both for the Treatment of Disseminated Mycobacterium avium Complex Disease in Persons with Acquired Immunodeficiency Syndrome // Clin. Infect. Dis… 2003. Vol. 37, Issue 9, No. 1 Р. 1234–1243. https://doi.org/10.1086/378807..
DOI: 10.1086/378807

Aberg J.A., Yajko D.M., Jacobson M.A. Eradication of AIDS-Related Disseminated Mycobacterium avium Complex Infection after 12 Months of Antimycobacterial Therapy Combined with Highly Active Antiretroviral Therapy // Journal of Infectious Diseases. 1998. Vol. 178, Issue 5. P. 1446–1449. https://doi.org/10.1086/314469..
DOI: 10.1086/314469

Ward T.T., Rimland D., Kauffman C. For the Veterans Affairs HIV Research Consortium, Randomized, Open-Label Trial of Azithromycin Plus Ethambutol vs. Clarithromycin Plus Ethambutol as Therapy for Mycobacterium avium Complex Bacteremia in Patients with Human Immunodeficiency Virus Infection // Clin. Infect. Dis. 1998. Vol. 27, Issue 5. Р. 1278–1285. doi: 10.1086/514999..
DOI: 10.1086/514999

Dunne М., Fessel J., Kumar P. A Randomized, Double-Blind Trial Comparing Azithromycin and Clarithromycin in the Treatment of Disseminated Mycobacterium avium Infection in Patients with Human Immunodeficiency Virus // Clin. Infect. Dis. 2000. Vol. 31, Issue 5, No. 15. Р. 1245–1252. doi: 10.1086/317468..
DOI: 10.1086/317468

Nakagawa T., Hashimoto H., Yagi M. et al. Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for noncavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol // BMJ Open Resp. Res. 2019. Vol. 6. e000434. doi: 10.1136/bmjresp-2019–000434 (intervention)..
DOI: 10.1136/bmjresp-2019–000434 (intervention)

Chaisson R.E., Keiser P., Pierce M. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection // AIDS. 1997. Vol. 11. Р. 311–317.

Fournier S., Burguiere A.M., Flahault A., Vincent V., Treilhou M.P., Eliaszewicz M. Effect of adding clofazimine to combined clarithromycinethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients // Eur. J. Clin. Microbiol. Infect Dis. 1999. Vol. 18. Р. 16–22.

Ferro B.E. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin // Antimicrobial agents and chemotherapy. 2015. 7 Dec., Vol. 60. No. 2. Р. 1097–1105. doi: 10.1128/AAC.02615-15..
DOI: 10.1128/AAC.02615-15

Nightingale S.D., Saletan S.L., Swenson C.E. Liposome-encapsulated gentamicin treatment of Mycobacterium avium–Mycobacterium intracellulare complex bacteremia in AIDS patients // Antimicrob Agents Chemother. 1993. Vol. 37. Р. 1869–1872.

Parenti D.M., Williams P.L., Hafner R. A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team // AIDS. 1998. Vol. 12. Р. 2439–2446.

Bermudez L.E., Kolonoski Р., Petrofsky М. Mefloquine, Moxifloxacin, and Ethambutol Are a Triple-Drug Alternative to Macrolide-Containing Regimens for Treatment of Mycobacterium avium Disease // J. Infectious Dis. 2003. Vol. 187, Issue 12. P. 1977–1980. https://doi.org/10.1086/375352..
DOI: 10.1086/375352

Koh Won-Jung. Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen // Antimicrobial agents and chemotherapy. 2013. Vol. 57, No. 5. Р. 2281–2285. doi: 10.1128/AAC.02281-12..
DOI: 10.1128/AAC.02281-12

Go-Eun Choi, Ki-Nam Min, Choul-Jae Won et al. Activities of Moxifloxacin in Combination with Macrolides against Clinical Isolates of Mycobacterium abscessus and Mycobacterium massiliense // Antimicrob. Agents and Chemotherapy Jun. 2012. Vol. 56, No 7. Р. 3549–3555. doi: 10.1128/AAC.00685-12..
DOI: 10.1128/AAC.00685-12

Rastogi N., Goh K.S., Bryskier A., Devallois A. In vitro activities of levofloxacin used alone and in combination with first- and second-line antituberculous drugs against Mycobacterium tuberculosis // Antimicrob. Agents Chemother. 1996. Vol. 40, No 7. Р. 1610–1616.

Shimomura H., Ono A., Imanaka K. Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease // J. Pharm. Health Care Sci. 2015. Vol. 1. Р. 24. Published 2015 Sep 3. doi: 10.1186/s40780-015-0025-4..
DOI: 10.1186/s40780-015-0025-4

Heifets L. Susceptibility testing of Mycobacterium avium complex isolates // Antimicrob. Agents Chemother. 1996. Vol. 40, No. 8. Р. 1759–1767.

Griffith D.E. Treatment of Mycobacterium avium Complex (MAC) // Semin. Respir. Crit. Care Med. 2018. Vol. 39, No 03. Р. 351–361. doi: 10.1055/s-0038-1660472..
DOI: 10.1055/s-0038-1660472

Kadota T., Matsui H., Hirose T. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease // BMC Infect. Dis. 2016. Vol. 16. Р. 31. Published 2016 Jan 27. doi: 10.1186/s12879-016-1384-7..
DOI: 10.1186/s12879-016-1384-7

Van Ingen J., Boeree M.J., van Soolingen D., Mouton J.W. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria // Drug Resistance Updates. 2012. Vol. 15, Issue 3. Р. 149–161. https://doi.org/10.1016/j.drup.2012.04.001..
DOI: 10.1016/j.drup.2012.04.001

Nannini E.C. Successful Treatment of Refractory Disseminated Mycobacterium avium Complex Infection with the Addition of Linezolid and Mefloquine // J. Infection. Vol. 44, Issue 3. Р. 201–203.

Vesenbeckh S., Schönfeld N., Krieger D. Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections // Europ. Respiratory J. 2017. Mar., Vol. 49, No 3. 1601969. doi: 10.1183/13993003.01969-2016..
DOI: 10.1183/13993003.01969-2016

Martin А., Godino I.T., Aguilar-Ayala D.A. In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria // J. Med. Microbiol. Vol. 68, No. 8. https://doi.org/10.1099/jmm.0.001025..
DOI: 10.1099/jmm.0.001025

Nakagawa T., Hashimoto H., Yagi M. Multicentre. Open label, randomised controlled trial comparing intermittent versus daily treatment for noncavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol // BMJ Open Respir. Res. 2019. Nо. 6 (1): e000434. Published 2019 May 30. doi: 10.1136/bmjresp-2019-000434..
DOI: 10.1136/bmjresp-2019-000434

Зюзя Ю.Р., Кузина М.Г., Пархоменко Ю.Г. Морфологические особенности микобактериозов, вызванных нетуберкулезными микобактериями // Клиническая и экспериментальная морфология. 2017. № 4 (24). С. 4–14.

Смирнова Т.Г., Андреевская С.Н., Ларионова Е.Е., Андриевская И.Ю., Устинова В.В., Черноусова Л.Н. Мониторинг видового разнообразия нетуберкулезных микобактерий в ряде областей РФ с использованием ДНК-стрипов genotype mycobacterium cm/as (Hain lifescience, Германия) // Туберкулез и болезни легких. 2017. № 95 (5). С. 54–59. https://doi.org/10.21292/2075-1230-2017-95-5-54-59..
DOI: 10.21292/2075-1230-2017-95-5-54-59

Гунтупова Л.Д., Борисов С.Е., Соловьева И.П., Макарова М.В., Хачатурьянц Е.Н. Микобактериозы во фтизиопульмонологической практике: обзор литературы и собственный опыт // Практическая медицина. 2011. № 51. С. 39–50.

Эргешов А.Э., Шмелев Е.И., Ковалевская М.Н., Карпина Н.Л., Ларионова Е.Е., Черноусова Л.Н. Микобактериозы в практике врачей пульмонологов и фтизиатров // Туберкулез и болезни легких. 2016. № 94 (9). С. 39–43. https://doi.org/10.21292/2075-1230-2016-94-9-39-43..
DOI: 10.21292/2075-1230-2016-94-9-39-43

Андреевская С.Н., Ларионова Е.Е., Смирнова Т.Г., Андриевская И.Ю., Киселева Е.А., Черноусова Л.Н. Лекарственная чувствительность медленнорастущих нетуберкулезных микобактерий // Туберкулез и болезни легких. 2016. Т. 94, № 4. С. 43–50. https://doi.org/10.21292/2075-1230-2016-94-4-43-50..
DOI: 10.21292/2075-1230-2016-94-4-43-50

Зимина В.Н., Дегтярева С.Ю., Белобородова Е.Н., Кулабухова Е.И., Русакова Л.И., Фесенко О.В. Микобактериозы: современное состояние проблемы // Клиническая микробиология и антимикробная химиотерапия. 2017. № 19 (4). С. 276–282.

Karakousis P.C., Moore R.D., Chaisson R.E. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy // Lancet Infect Dis. 2004. Sep; Vol. 4, No. 9. Р. 557–565. DOI: 10.1016/S1473-3099(04)01130-2..
DOI: 10.1016/S1473-3099(04)01130-2